Paul Reider Coherus Bio Sciences, Inc. (CHRS) insider trading activity

Paul Reider is Chief Commercial Officer of Coherus BioSciences, Inc.. Currently has a direct ownership of 82,069 shares of CHRS, which is worth approximately $96,841. The most recent transaction as insider was on Jan 20, 2025, when has been sold 4,858 shares (Common Stock) at a price of $1.39 per share, resulting in proceeds of $6,752. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 82.1K

0.97% 3M change

0.97% 12M change

Total Value Held $96,841

Paul Reider Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 20 2025	SELL Payment of exercise price or tax liability	$6,752 $1.39 p/Share	4,858 Reduced 5.59%	82,069 Common Stock
Jan 04 2025	SELL Payment of exercise price or tax liability	$3,779 $1.66 p/Share	2,277 Reduced 2.55%	86,927 Common Stock
Dec 13 2024	SELL Payment of exercise price or tax liability	$3,337 $1.61 p/Share	2,073 Reduced 2.27%	89,204 Common Stock
Jan 20 2024	SELL Payment of exercise price or tax liability	$11,843 $2.44 p/Share	4,854 Reduced 5.64%	81,277 Common Stock
Jan 04 2024	SELL Payment of exercise price or tax liability	$6,643 $2.92 p/Share	2,275 Reduced 2.57%	86,131 Common Stock
Dec 13 2023	SELL Payment of exercise price or tax liability	$4,856 $2.37 p/Share	2,049 Reduced 2.27%	88,406 Common Stock
Apr 01 2023	SELL Payment of exercise price or tax liability	$16,764 $6.84 p/Share	2,451 Reduced 2.74%	87,053 Common Stock

Paul Reider

Chief Commercial Officer

Redwood City, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CHRS shares.

Notify only if

Value

Insider Trading

Get notified when an Coherus Bio Sciences, Inc. insider buys or sells CHRS shares.

Notify only if

Operation

Value

Type

News

Receive news related to Coherus BioSciences, Inc.

Track Activities on CHRS

Account